Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE
多马替诺(4SC-202)联合阿维鲁单抗治疗既往接受过治疗的晚期错配修复功能正常的食管胃癌和结直肠腺癌患者的II期临床试验:EMERGE
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.102971
Cartwright, E; Slater, S; Saffery, C; Tran, A; Turkes, F; Smith, G; Aresu, M; Kohoutova, D; Terlizzo, M; Zhitkov, O; Rana, I; Johnston, E W; Sanna, I; Smyth, E; Mansoor, W; Fribbens, C; Rao, S; Chau, I; Starling, N; Cunningham, D